Skip to main content

Published locations for Ipilimumab Extends Survival in Melanoma : Median survival was about 10 months in patients who received the agent vs. 6.4 months without it.

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ipilimumab Extends Survival in Melanoma : Median survival was about 10 months in patients who received the agent vs. 6.4 months without it.

User login

  • Reset your password
  • /content/ipilimumab-extends-survival-melanoma-median-survival-was-about-10-months-patients-who
  • /familypracticenews/article/31313/dermatology/ipilimumab-extends-survival-melanoma-median-survival
  • /ehospitalistnews/article/31313/dermatology/ipilimumab-extends-survival-melanoma-median-survival-was
  • /familymedicine/article/31313/dermatology/ipilimumab-extends-survival-melanoma-median-survival-was